Iqvia Holdings (IQV) Profit After Tax (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Profit After Tax came in at $258.0 million in Q2 2026, down 3.37% year-over-year from $267.0 million in Q2 2025, and down 6.18% quarter-over-quarter from $275.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Profit After Tax (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Profit After Tax across 15 years of filings, most recently posting $258.0 million for Q2 2026.
- In Q2 2026, Profit After Tax fell 3.37% year-over-year to $258.0 million; the TTM figure through Jun 2026 stood at $1.4 billion (up 10.26% YoY), while the FY2025 annual figure was $1.4 billion, down 0.87% from the prior year.
- Profit After Tax came in at $258.0 million for Q2 2026 at Iqvia Holdings, down from $275.0 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $500.0 million in Q4 2025 to a low of $227.0 million in Q4 2022.
- Average Profit After Tax over 5 years is $317.2 million, with a median of $289.0 million recorded in 2022.
- Year-over-year, Profit After Tax retreated 28.62% in 2022 and jumped 106.61% in 2023.
- Over 5 years, Profit After Tax stood at $227.0 million in 2022, then surged by 106.61% to $469.0 million in 2023, then decreased by 6.82% to $437.0 million in 2024, then climbed by 14.42% to $500.0 million in 2025, then plunged by 48.4% to $258.0 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $258.0 million in Q2 2026, $275.0 million in Q1 2026, and $500.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 258.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 72.58 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -1.48 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -57.32 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -426,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -4.36 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 258.00 Mn |
| Mar 31, 2026 | 275.00 Mn |
| Dec 31, 2025 | 500.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 267.00 Mn |
| Mar 31, 2025 | 249.00 Mn |
| Dec 31, 2024 | 437.00 Mn |
| Sep 30, 2024 | 285.00 Mn |
| Jun 30, 2024 | 363.00 Mn |
| Mar 31, 2024 | 288.00 Mn |
| Dec 31, 2023 | 469.00 Mn |
| Sep 30, 2023 | 303.00 Mn |
| Jun 30, 2023 | 297.00 Mn |
| Mar 31, 2023 | 289.00 Mn |
| Dec 31, 2022 | 227.00 Mn |
| Sep 30, 2022 | 289.00 Mn |
| Jun 30, 2022 | 256.00 Mn |
| Mar 31, 2022 | 325.00 Mn |
| Dec 31, 2021 | 318.00 Mn |
| Sep 30, 2021 | 261.00 Mn |